CHRONIC HEPATITIS B (HBEAG-NEGATIVE)

Clinical trials for CHRONIC HEPATITIS B (HBEAG-NEGATIVE) explained in plain language.

Never miss a new study

Get alerted when new CHRONIC HEPATITIS B (HBEAG-NEGATIVE) trials appear

Sign up with your email to follow new studies for CHRONIC HEPATITIS B (HBEAG-NEGATIVE), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

Hepatitis b hope: adding interferon may help clear virus marker

Disease control Completed

This study tested whether adding a 48-week course of pegylated interferon to standard antiviral pills could help people with chronic hepatitis B lose a key virus marker (HBsAg). 119 adults with HBeAg-negative hepatitis B who had been on standard treatment for at least 2 years too…

Matched conditions: CHRONIC HEPATITIS B (HBEAG-NEGATIVE)

Phase: NA • Sponsor: José Antonio Carrion • Aim: Disease control

Last updated May 08, 2026 12:01 UTC

CHRONIC HEPATITIS B (HBEAG-NEGATIVE)

Get alerted when new CHRONIC HEPATITIS B (HBEAG-NEGATIVE) trials appear

Hepatitis b hope: adding interferon may help clear virus marker